Finance

Beta
Lists
300138:SHE
Chenguang Biotech Group Co Ltd
CN¥9.98
+1.22%
(+0.12) 1D
Jun 5, 3:04:46 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300138...
Open
CN¥9.88
High
CN¥10.12
Low
CN¥9.76
Mkt. cap
4.76B
Avg. vol.
6.16M
Volume
5.25M
Dividend
3.01%
Quarterly dividend
CN¥0.08
Ex-dividend date
May 21, 2026
P/E ratio
13.54
52-wk high
CN¥15.80
52-wk low
CN¥9.76
EPS
CN¥0.74
Shares outstanding
483.10M
No. of employees
2K
Open
CN¥9.88
High
CN¥10.12
Low
CN¥9.76
Mkt. cap
4.76B
Avg. vol.
6.16M
Volume
5.25M
Dividend
3.01%
Quarterly dividend
CN¥0.08
Ex-dividend date
May 21, 2026
P/E ratio
13.54
52-wk high
CN¥15.80
52-wk low
CN¥9.76
EPS
CN¥0.74
Shares outstanding
483.10M
No. of employees
2K
News stories
From sources across the web
About Chenguang Biotech Group Co Ltd
CEO-
Employees2.08K
FoundedApr 12, 2000
Headquarters-
SectorFood
Websitecn-cg.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.94B
1.39B
1.51B
1.63B
Cost of goods sold
1.69B
1.15B
1.42B
1.41B
Cost of revenue
1.69B
1.15B
1.42B
1.41B
Research and development expenses
70.64M
47.11M
6.75M
33.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58.81M
67.39M
45.84M
49.61M
Operating expense
135.38M
105.01M
75.42M
80.85M
Total operating expenses
1.83B
1.26B
1.49B
1.49B
Operating income
114.48M
133.00M
18.09M
142.00M
Other non operating income
-4.29M
4.98M
-2.66M
-5.48M
EBT including unusual items
133.58M
105.49M
67.52M
113.88M
EBT excluding unusual items
112.55M
140.83M
14.91M
119.78M
Income tax expense
23.51M
15.41M
3.98M
15.48M
Effective tax rate
17.60%
14.61%
5.89%
13.59%
Other operating expenses
6.26M
-11.81M
16.85M
-1.67M
Net income
105.49M
88.86M
65.04M
96.72M
Net profit margin
5.43%
6.39%
4.30%
5.94%
Earnings per share
-
-
-
-
Interest and investment income
26.37M
15.01M
20.93M
12.24M
Interest expense
-24.90M
-11.28M
-20.79M
-28.98M
Net interest expenses
1.47M
3.73M
143.27K
-16.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
159.24M
174.56M
63.72M
187.63M
Gain or loss from assets sale
-3.98M
3.98M
-1.46M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more